Does promoter Methylation of CDO1 identify Clear-Cell Renal Cell Cancer Patients with Poor Survival Outcome?
CDO1 promoter methylation may not substitute common prognostic makers to predict ccRCC survival, but offers additional, relevant prognostic information, indicating that it might be a novel molecular marker to determine ccRCC prognosis.
Levels of BNP can serve as a marker of left atrial thrombus in acute ischemic stroke and TIA in patients with AF.